Ghilardi Giorgio, Biondi Maria Luisa, Battaglioli Lodovica, Zambon Antonella, Guagnellini Emma, Scorza Roberto
Dipartimento MCO, Clinica Chirurgica Generale, Università degli Studi di Milano-Polo Didattico S. Paolo, 9 I-20142 Milano, Italy.
J Vasc Surg. 2004 Nov;40(5):995-1000. doi: 10.1016/j.jvs.2004.08.014.
Inflammation is involved in the pathogenesis of atherosclerosis and abdominal aortic aneurysm (AAA), and chemokines are mediators of the inflammatory process. The homozygous Delta 32 deletion mutation of the gene of the chemokine receptor CCR5 is a cause of its lack in inflammatory cells. The purpose of this study was to investigate the relationship between CCR5 Delta 32 deletion mutation and AAA, peripheral arterial occlusive disease (PAOD), and carotid stenosis.
The CCR5 Delta 32 polymorphism was genotyped in 380 subjects: 70 patients operated on to treat AAA (21 ruptured AAAs, 49 elective repair), 76 patients with PAOD, 62 patients with carotid stenosis, and 172 age-matched and sex-matched healthy control subjects. Risk factors for AAA were considered. Each patient was assessed according to a diagnostic procedure tailored to symptoms at presentation.
In patients with AAA the Delta allelic variation was significantly different compared with control subjects (P = .002; odds ratio [OR], 2.7; 95% confidence interval [CI], 1.41-5.15). The increased presence of this allele differentiates AAA from both PAOD (P = .017; OR, 2.77; 95% CI, 1.17-6.52) and carotid stenosis (P = .01; OR, 3.47; 95% CI, 1.31-9.11). The presence in the genotype of patients with AAA of at least 1 Delta 32 allele is more frequent in ruptured AAAs than in electively repaired AAAs (genotype: OR, 4.04; 95% CI, 1.34-12.1; P = .011; allelic frequency: OR, 2.75; 95% CI, 1.07-7.07; P = .035). Among the patients, multiple regression analysis showed that the Delta 32 allele is an independent risk factor for AAA vs PAOD (OR, 3.13; 95% CI, 1.33-7.33; P = .012) and for ruptured AAAs vs electively repaired AAAs (OR, 3.52; 95% CI, 1.01-11.80; P = .045).
CCR5 Delta 32 deletion mutation is significantly more frequent in patients with AAA than in control subjects and in both patients with PAOD and carotid stenosis, and could be a factor that differentiates AAA from PAOD, and ruptured AAAs from AAAs that can be electively repaired.
The major threat of abdominal aortic aneurysm (AAA) is rupture, accounting for extremely high mortality. This occurrence has been correlated to aneurysm size, but it is a common observation that small AAAs can rupture and large AAAs can remain stable for many years. This study was carried out in an attempt to search for genetic markers of aneurysm rupture. Some single nucleotide polymorphisms are implicated in acceleration of transcription for enzymes involved in the inflammatory process and in extracellular matrix remodeling. An association between single nucleotide polymorphisms and aneurysm rupture could enable better selection for surgical indications in patients with small AAs and in patients at poor risk with large AAAs.
炎症参与动脉粥样硬化和腹主动脉瘤(AAA)的发病机制,趋化因子是炎症过程的介质。趋化因子受体CCR5基因的纯合Δ32缺失突变是其在炎症细胞中缺乏的原因。本研究的目的是探讨CCR5 Δ32缺失突变与AAA、外周动脉闭塞性疾病(PAOD)和颈动脉狭窄之间的关系。
对380名受试者进行CCR5 Δ32多态性基因分型:70例接受AAA治疗的患者(21例破裂性AAA,49例择期修复),76例PAOD患者,62例颈动脉狭窄患者,以及172例年龄和性别匹配的健康对照者。考虑了AAA的危险因素。根据针对就诊时症状定制的诊断程序对每位患者进行评估。
AAA患者的Δ等位基因变异与对照者相比有显著差异(P = 0.002;比值比[OR],2.7;95%置信区间[CI],1.41 - 5.15)。该等位基因的增加存在使AAA与PAOD(P = 0.017;OR,2.77;95% CI,1.17 - 6.52)和颈动脉狭窄(P = 0.01;OR,3.47;95% CI,1.31 - 9.11)相区分。AAA患者基因型中至少有1个Δ32等位基因的情况在破裂性AAA中比在择期修复的AAA中更常见(基因型:OR,4.04;95% CI,1.34 - 12.1;P = 0.011;等位基因频率:OR,2.75;95% CI,1.07 - 7.07;P = 0.035)。在患者中,多元回归分析表明,Δ32等位基因是AAA与PAOD相比(OR,3.13;95% CI,1.33 - 7.33;P = 0.012)以及破裂性AAA与择期修复的AAA相比(OR,3.52;95% CI,1.01 - 11.80;P = 0.045)的独立危险因素。
CCR5 Δ32缺失突变在AAA患者中比在对照者以及PAOD和颈动脉狭窄患者中显著更常见,并且可能是区分AAA与PAOD以及破裂性AAA与可择期修复的AAA的一个因素。
腹主动脉瘤(AAA)的主要威胁是破裂,死亡率极高。这种情况与动脉瘤大小相关,但常见的观察是小的AAA会破裂而大的AAA可以多年保持稳定状态。本研究旨在寻找动脉瘤破裂的遗传标志物。一些单核苷酸多态性与炎症过程中涉及的酶以及细胞外基质重塑的转录加速有关。单核苷酸多态性与动脉瘤破裂之间的关联可以使对小AAA患者和大AAA风险较差患者的手术指征选择更加合理。